American Vietnamese Biotech (AMV.VN) Stock Price
American Vietnamese Biotech Price
Over the last 16 years American Vietnamese Biotech grew revenue by 28.2% annually, reaching 310.35 B VND. Earnings per share have declined at 9.4% per year over the last 15 years. For American Vietnamese Biotech, the net margin of -3.6% is down versus 52.2% a few years ago. At today's price the dividend yield works out to roughly 0.74%. The payout ratio is around 1% of earnings.
American Vietnamese Biotech stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
American Vietnamese Biotech business model & stock analysis
Frequently asked questions about American Vietnamese Biotech
Converted at the current exchange rate, the American Vietnamese Biotech share trades at 0.04 EUR (1,300.00 VND).
The revenue cannot currently be calculated for American Vietnamese Biotech.
The profit cannot currently be calculated for American Vietnamese Biotech.
The P/E ratio cannot be calculated for American Vietnamese Biotech at the moment.
The P/S cannot be calculated for American Vietnamese Biotech currently.
The Eulerpool Quality Score for American Vietnamese Biotech is 3/10.
The ISIN of American Vietnamese Biotech is VN000000AMV5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of American Vietnamese Biotech is AMV.VN. The ticker symbol is used to trade American Vietnamese Biotech shares on the stock exchange.
American Vietnamese Biotech stock
American Vietnamese Biotech Peer Group
American Vietnamese Biotech FIGI
All fundamentals and in-depth analysis of American Vietnamese Biotech
Our stock analysis for American Vietnamese Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of American Vietnamese Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.